Physician profile
Premranjan Singh
NPI 1114113719
$26,395.10
in general payments reported to CMS, 2019-2025
48 companies · $4,771 in 2025
The $4,771 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,229 · 2020: $577 · 2021: $4,787 · 2022: $2,728 · 2023: $4,200 · 2024: $3,103 · 2025: $4,771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,998 · Consulting Fee: $3,324 · Travel and Lodging: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,997.72 |
| Consulting Fee | $3,324.00 |
| Travel and Lodging | $752.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,729.61 | 2019-2024 | Indigo System, Penumbra System |
| Ge Healthcare | $3,324.00 | 2025 | |
| Boston Scientific Corporation | $2,370.68 | 2019-2025 | Varithena Administration Pack, Farapulse, Avvigo Guidance System |
| Angiodynamics, INC. | $1,425.05 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $1,393.92 | 2019-2025 | Jot Dx, Aveir, Navitor |
| Janssen Pharmaceuticals, INC | $1,153.32 | 2019-2024 | Xarelto |
| Abiomed | $975.99 | 2019-2025 | Impella |
| Amgen INC. | $967.36 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $929.65 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $886.89 | 2019-2024 | Jardiance |
| Shockwave Medical, INC | $864.41 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $789.16 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Medtronic Vascular, INC. | $640.94 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $563.46 | 2019-2025 | Brilinta |
| Merck Sharp & Dohme LLC | $563.07 | 2021-2025 | Verquvo, Capvaxive |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $445.23 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $383.61 | 2019-2024 | |
| Impulse Dynamics (USA) INC. | $364.09 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $343.72 | 2019-2024 | Lifevest |
| Limflow INC. | $329.52 | 2023 | Limflow System |
| Teleflex LLC | $318.75 | 2024 | Manta |
| Sanofi-Aventis U.S. LLC | $274.11 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $266.33 | 2021-2024 | Eliquis, Camzyos |
| United Therapeutics Corporation | $254.03 | 2019 | |
| Esperion Therapeutics, INC. | $240.53 | 2021-2025 | Nexletol |
| Cook Medical LLC | $201.31 | 2021-2025 | Zilver Ptx, Advance, Zilver Vena |
| Lexicon Pharmaceuticals, INC. | $196.04 | 2023-2024 | Inpefa |
| Biotronik INC. | $191.57 | 2021 | |
| Stryker Corporation | $124.78 | 2021 | |
| Amarin Pharma, INC. | $119.51 | 2019-2020 | |
| Philips North America LLC | $106.69 | 2019-2024 | (Cm9) Amb Mon & Diag Und |
| Kestra Medical Technology Services, INC. | $92.07 | 2023-2025 | Assure Wcd |
| Atricure, INC. | $83.03 | 2023-2024 | |
| Elutia, INC. | $67.95 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $67.50 | 2019-2023 | Evkeeza |
| Astellas Pharma US INC | $51.84 | 2019-2020 | |
| Inari Medical, INC. | $49.39 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bayer Healthcare Pharmaceuticals INC. | $46.45 | 2021-2022 | |
| Bardy Diagnostics, INC. | $42.00 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $25.85 | 2019 | |
| Cardiovascular Systems INC. | $23.28 | 2019 | |
| Bard Peripheral Vascular, INC. | $23.07 | 2025 | Rotarexs 6 F X 135 Cm |
| Alnylam Pharmaceuticals INC. | $22.09 | 2021 | |
| Allergan, INC. | $18.78 | 2019 | |
| Lundbeck LLC | $17.79 | 2019 | |
| Gilead Sciences, INC. | $15.51 | 2019 | |
| Cashflow Solutions, LLC | $11.17 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$200,002.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Premranjan Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.